EPA:SAN • FR0000120578
This SAN.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
Overall SAN gets a fundamental rating of 5 out of 10. We evaluated SAN against 54 industry peers in the Pharmaceuticals industry. Both the profitability and the financial health of SAN get a neutral evaluation. Nothing too spectacular is happening here. SAN has a decent growth rate and is not valued too expensively. Finally SAN also has an excellent dividend rating. With these ratings, SAN could be worth investigating further for dividend investing!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.85% | ||
| ROE | 17.49% | ||
| ROIC | 13.76% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.28% | ||
| PM (TTM) | 17.71% | ||
| GM | 72.55% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.22 | ||
| Debt/FCF | 1.86 | ||
| Altman-Z | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.09 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.75 | ||
| Fwd PE | 8.99 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.87 | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.3% |
EPA:SAN (3/11/2026, 7:00:00 PM)
76.25
-0.06 (-0.08%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.3% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.75 | ||
| Fwd PE | 8.99 | ||
| P/S | 2.61 | ||
| P/FCF | 16.87 | ||
| P/OCF | 16.87 | ||
| P/B | 2.58 | ||
| P/tB | 48.27 | ||
| EV/EBITDA | N/A |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.85% | ||
| ROE | 17.49% | ||
| ROCE | 16.67% | ||
| ROIC | 13.76% | ||
| ROICexc | 14.92% | ||
| ROICexgc | 58.3% | ||
| OM | 23.28% | ||
| PM (TTM) | 17.71% | ||
| GM | 72.55% | ||
| FCFM | 15.49% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.22 | ||
| Debt/FCF | 1.86 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 87.43% | ||
| Current Ratio | 1.09 | ||
| Quick Ratio | 1.09 | ||
| Altman-Z | N/A |
ChartMill assigns a fundamental rating of 5 / 10 to SAN.PA.
ChartMill assigns a valuation rating of 6 / 10 to SANOFI (SAN.PA). This can be considered as Fairly Valued.
SANOFI (SAN.PA) has a profitability rating of 6 / 10.
The Price/Earnings (PE) ratio for SANOFI (SAN.PA) is 9.75 and the Price/Book (PB) ratio is 2.58.
The financial health rating of SANOFI (SAN.PA) is 5 / 10.